MEOH METHANEX CORP IFRS Annual reports only
Industrial Organic Chemicals · Nasdaq · SEC CIK 886977 · Fiscal year ends 12/31
Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $3.59B | $3.72B | $3.72B | $4.31B | $4.41B |
| Cost of revenue | $2.31B | $2.68B | $2.80B | $3.24B | $3.11B |
| Gross profit | $1.28B | $1.04B | $925.68M | $1.07B | $1.30B |
| Operating income | $431.06M | $361.96M | $263.57M | $610.61M | $711.97M |
| Interest expense | $219.69M | $132.63M | $117.37M | $130.75M | $144.41M |
| Pretax income | $203.24M | $280.09M | $285.61M | $582.15M | $666.34M |
| Income tax | $58.45M | $29.84M | $1.49M | $119.86M | $110.43M |
| Net income | $79.88M | $163.99M | $174.14M | $353.83M | $482.36M |
| EBITDA | $877.07M | $747.67M | $655.40M | $983.03M | $1.08B |
| EPS (basic) | 1.10 | 2.43 | 2.57 | 4.95 | 6.34 |
| EPS (diluted) | 0.93 | 2.39 | 2.57 | 4.86 | 6.13 |
| Dividends declared per share | 0.74 | 0.73 | 0.73 | 0.62 | 0.33 |
| Weighted avg. shares (diluted) | 72.61M | 67.56M | 67.81M | 71.68M | 76.24M |
| Balance sheet | |||||
| Cash & equivalents | $425.33M | $891.91M | $458.01M | $857.75M | $932.07M |
| Receivables | $463.01M | $473.34M | $533.62M | $500.93M | $551.37M |
| Inventory | $494.67M | $453.46M | $426.77M | $439.77M | $459.56M |
| Current assets | $1.49B | $1.91B | $1.48B | $1.88B | $1.99B |
| PP&E, netmay include right-of-use assets (IFRS) | $4.58B | $3.50B | $3.65B | $3.40B | $3.08B |
| Total assets | $7.28B | $6.60B | $6.43B | $6.63B | $6.09B |
| Current liabilities | $721.74M | $729.62M | $1.30B | $942.62M | $963.22M |
| Short-term debt | $41.36M | $13.73M | $314.72M | $15.13M | $11.78M |
| Long-term debt | $2.71B | $2.40B | $1.83B | $2.14B | $2.15B |
| Total debt | $2.75B | $2.41B | $2.14B | $2.15B | $2.16B |
| Total liabilities | $4.56B | $4.22B | $4.25B | $4.20B | $4.13B |
| Shareholders' equity | $2.44B | $2.09B | $1.93B | $2.11B | $1.68B |
| Net debt | $2.33B | $1.52B | $1.68B | $1.29B | $1.23B |
| Cash flow statement | |||||
| Operating cash flow | $1.02B | $737.18M | $660.27M | $987.35M | $994.37M |
| Capital expenditure | $98.99M | $101.26M | $178.46M | $145.70M | $103.48M |
| Free cash flow | $916.57M | $635.92M | $481.81M | $841.65M | $890.88M |
| Investing cash flow | -$1.36B | -$99.74M | -$508.58M | -$553.14M | -$253.05M |
| Financing cash flow | -$125.76M | -$203.55M | -$551.42M | -$508.53M | -$643.09M |
| Depreciation & amortization | $446.01M | $385.70M | $391.83M | $372.42M | $363.08M |
| Stock-based compensation | -$4.43M | $23.97M | $34.50M | $15.40M | -$1.16M |
| Dividends paid | $53.55M | $49.87M | $49.38M | $43.95M | $24.63M |
| Share buybacks | — | $0 | $86.39M | $252.99M | $62.90M |
Free plan shows the latest 5 periods; Pro shows all 10 🔒
· This company reports under IFRS: some line items differ from US GAAP — operating income is not required, interest expense may be broader "finance costs", and banks have no standard revenue line.
· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.